Gender Issues in Depression

References

• Kessler RC, McGonagle KA, Swartz M Blazer DG, Nelson CB: Sex and depression in the National Comorbidity Survey I. Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993; 29:85–96
   Google Scholar
• Rowe SK, Rapaport MH: Classification and treatment of sub-threshold depression. Curr Opin Psychiatry 2006;19:1–13
   Google Scholar
• Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP, Kunovac IL, Leon AC, Mueller TI, Rice JA, Keller MB: A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998; 55:694–700
   PubMed Web of Science ®Google Scholar
• Hu TW: Perspectives: an international review of the national cost estimates of mental illness, 1990-2003. J Ment Health Policy Econ 2006; 9:3–13
   PubMed Web of Science ®Google Scholar
• Michaud CM, Murray CJ, Bloom BR: Burden of disease: Implica-tions for future research. JAMA 2001; 285:535–539
   PubMed Web of Science ®Google Scholar
• Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Wisniewski SR, Fava M, Hughes CW, Garber J, Malloy E, King CA, Cerda G, Sood AB, Alpert JE, Trivedi MH, Rush AJ, Star*D-Child Team: Remissions in maternal depression and child psycho-pathology: a STAR*D-child report. JAMA 2006; 295:1389–1398
   PubMed Web of Science ®Google Scholar
• Kessler R: Gender differences in the prevalence and correlates of mood disorders in the general population. In: Steiner M, Yonkers KA, Eriksson E eds. Mood Disorders in Women. London, England: Martin Dunitz Ltd.: 2000:15–35
   Google Scholar
• Kuehner C: Gender differences in unipolar depression: An update of epidemiological findings and possible explanations. Acta Psy-chiatr Scand 2003; 108:163–174
   PubMed Web of Science ®Google Scholar
• Weissman MM, Bruce LM, Lief, PJ, Florio, LP, Holzer, C: Affec-tive disorders In: Robins LN, Regier DA, eds. Psychiatric Disor-ders in America: The Epidemiologic Catchment Area Study. New York, NY: The Free Press: 1991:53–80
   Google Scholar
• O. Kessler RC, McConagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States. Arch Gen Psychiatry 1994; 51:8–19
   Google Scholar
• Hasin DS, Goodwin RD, Stinson FS, Grant BF: Epidemiology of major depressive disorder: Results from the National Epidemio-logic Survey on Alcoholism and Related Conditions. Archives of General Psychiatry 2005; 62: 1097–106
   PubMed Web of Science ®Google Scholar
• Leibenluft E, Hardin TA, Rosenthal NE: Gender differences in seasonal affective disorder. Depression 1998; 3:13–19
   Google Scholar
• Hirschfeld RMA, Klerman GL, Clayton PJ, Keller MB, Andrea-son NC: Personality and gender-related differences in depression. J Affect Disord 1984; 7:211–221
   PubMedGoogle Scholar
• Kornstein SG, Schatzberg AE, Thase ME: Gender differences in chronic major depression and double depression. J Affect Disord 2000; 60:1–11
   PubMed Web of Science ®Google Scholar
• Regier D, Rae D, Narrow W, Kaelber CT, Schatzberg AF: Preva-lence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry 1998; 34:24–28
   Google Scholar
• Weiss EL, Longhurst JG, Mazure CM: Childhood sexual abuse as a risk factor for depression in women: Psychosocial and neurobio-logical correlates. Am J Psychiatry 1999; 156:816–828
   PubMed Web of Science ®Google Scholar
• Kessler RC: Gender differences in major depression. Epidemio-logical findings. In: Frank E ed. Gender and its Effects on Psycho-pathology. Washington, DC: American Psychiatric Press: 2000: 61–84
   Google Scholar
• Bebbington PE, Dunn G, Jenkins R, Lewis G, Brugha T, Farrell M, Meltzer H : The influence of age and sex on the prevalence of depressive conditions: Report from the National Survey of Psy-chiatric Comorbidity. Psychol Med 1998; 28:9–19
   PubMed Web of Science ®Google Scholar
• Wang IL: The difference between single and married mothers in the 12-month prevalence of major depressive syndrome, associated factors and mental health service utilization. Soc Psy-chiatry Psychiatr Epidemiol 2004; 39:26–32
   PubMed Web of Science ®Google Scholar
• Pajer K: New strategies in the treatment of depression in women. J Clin Psychiatry 1995; 56:30–37
   PubMed Web of Science ®Google Scholar
• Astbury A, Cabral M: Women's mental health: An evidence based review. Geneva: World Health Organization, 2000
   Google Scholar
• Krystal III, D'Souza DC, Sanacora G, Goddard AW, Chamey DS: Current perspectives on the pathophysiology of schizophre-nia, depression, and anxiety disorders. Med Clin N Am 2001; 85:559–577
   Google Scholar
• Vaidya VA, Duman RS: Depression-emerging insights from neurobiology. Br Med Bull 2001; 57:61–79
   Google Scholar
• Hashimoto K, Shimizu E, Iyo M: Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004; 45:104–114
   PubMedGoogle Scholar
• Varghese FP, Brown ES: The hypothalamic-pituitary-adrenal axis in major depressive disorder: A brief primer for primary care phy-sicians. Prim Care Companion J Clin Psychiatry 2001; 3:151–155
   PubMedGoogle Scholar
• Claes SJ: Corticotropin-releasing hormone (CRH) in psychiatry: From stress to psychopathology. Ann Med 2004; 36:50–61
   PubMed Web of Science ®Google Scholar
• Campbell S, Marriott M, Nahmias C, MacQueen GM: Lower hip-pocampal volume in patients suffering from depression: A meta-analysis. Am J Psychiatry 2004; 161:598–607
   PubMed Web of Science ®Google Scholar
• Blumberg HP, Leung H-C, Skudlarski P. Lacadi CM, Fredericks CA, Harris BC, Chamey DS, Gore JC, Krystal HI, Peterson BS: A functional magnetic resonance imaging study of bipolar disor-der: state- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 2003; 60:601–609
   Google Scholar
• Ostlund H, Keller E, Hurd YL: Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann N Y Acad Sci. 2003; 1007:54–63
   PubMed Web of Science ®Google Scholar
• Fink G, Sumner BE, Rosie R. Grace 0, Quinn JP: Estrogen con-trol of central eurotransmission: Effect on mood, mental state and memory. Cell. Mol. Neurobiol 1996; 16:325–344
   Google Scholar
• Fountoulakis KN, Iacovides A, Grammaticos P, St Kaprinis G, Bech P: Thyroid function in clinical subtypes of major depres-sion: An exploratory study. BMC Psychiatry 2004; 4:6
   PubMed Web of Science ®Google Scholar
• Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ: A lon-gitudinal twin study of 1-year prevalence of major depression in women. Arch Gen Psychiatr 1993; 50:843–852
   PubMed Web of Science ®Google Scholar
• Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington HL, McClay J, Mill J, Martin J, Braithwaite A, Poulton R: Influ-ence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 2003; 301:386–389
   PubMed Web of Science ®Google Scholar
• Whitely BE Jr: Sex role orientation and psychological well-being: Two meta-analyses. Sex Roles 1985; 12:207–225
   Google Scholar
• Warren LW, MacEachren L: Psychosocial correlates of depres-sive symptomatology in adult women. J Abnorm Psycho 1983; 92:151–160
   PubMed Web of Science ®Google Scholar
• Duggan C, Sham P, Lee AS, Minne C, Murray, R. Neuroticism: A vulnerability marker for depression: evidence from a family study. J Affect Disord 1995; 35:139–143.
   PubMed Web of Science ®Google Scholar
• Goodwin RD, Gotlib 111: Gender differences in depression: The role of personality factors. Psychiatry Res. 2004; 126:135–142
   PubMed Web of Science ®Google Scholar
• Nolen-Hoeksema S: The role of rumination in depressive disor-ders and mixed anxiety/depressive symptoms. J Abnorm Psychol 2000; 109: 504–511
   PubMed Web of Science ®Google Scholar
• Shorter E, Tyrer P: Separation of anxiety and depressive disor-ders: Blind alley in psychopharmacology and classification of dis-ease. Brit Med J 2003,327:158–160
   PubMed Web of Science ®Google Scholar
• Jenkins R, Lewis G, Bebbington P. Brugha T, Farrell M, Gill B, Lewis G, Meltzr H, Petticrew M: The national psychiatric comor-bidity surveys of Great Britain-initial findings from the house-hold survey. Psychol Med 1997; 27:775–799
   Google Scholar
• Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Holton SD, Warden D, Biggs MM, Shores-Wilson K, Shelton RC, Luther IF, Thomas B, Trivedi MH: Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features. J Affect Disord 2005; 87:43–55
   PubMed Web of Science ®Google Scholar
• Simonds VM, Whiffen VE: Are gender differences in depression explained by gender differences in comorbid anxiety? J Affect Disord 2003; 77:197–202
   PubMed Web of Science ®Google Scholar
• Schoevers RA, Beekman ATF, Deeg DJH, Jonker C, van Tilburg W: Comorbidity and risk-patterns of depression, generalised anxi-ety disorder and mixed anxiety-depression in later life: Results from the AMSTEL study. Int J Geriatr Psychiatry 2003; 18:994–1001
   PubMed Web of Science ®Google Scholar
• Corruble E, Ginestet D, Guelfi JD: Comorbidity of personality disorders and unipolar major depression: A review. J Affect Dis-ord 1996; 37:157–170
   PubMed Web of Science ®Google Scholar
• Ekselius L, Bodlund 0, von Knorring L, Lindstrom E, Kullgren G: Sex differences in DSM-II1R, Axis II personality disorders. Pers Individ Diff 1996; 20:457–461
   Web of Science ®Google Scholar
• Rogers JH, Widiger TA, Krupp A: Aspects of depression associ-ated with borderline personality disorder. Am J Psychiatry 1985; 152:268–270
   Google Scholar
• Moscicki EK: Identification of risk factors using epidemio-logic studies. Psychiatric Clinics of North America 1997; 20:499–517
   PubMed Web of Science ®Google Scholar
• Isometsa ET, Henriksson MM, Aro H, Heikkinen ME, Kuoppasalmi KI, Lonnqvist JK: Suicide in major depression. Am J Psychiatry 1994; 151:530–536
   PubMed Web of Science ®Google Scholar
• Whybrow PC: Sex differences in thyroid axis dysfunction: Rele-vance to affective disorder and its treatment. Depression 1995; 3:33–42
   Google Scholar
• Burkhardt CS, O'Reilly CA, Wiens AN, Clark SR, Campbell SM, Bennett RM: Assessing depression on fibromyalgia patients. Arthritis Care Research 1994; 7:35–39
   Google Scholar
• Moldin SO, Scheftner WA, Rice JP, Nelson E, Knesevich MA, Akiskal H: Association between major depressive disorder and physical illness. Psychological Medicine 1993; 23:755–761
   PubMed Web of Science ®Google Scholar
• Sotsky SM, Glass DR, Shea MT, Pilkonis PA, Collins JF, Elkin I, Watkins JT, Imber SD, Leber WR, Moyer J: Patient predictors of response to psychotherapy and pharmacotherapy: Findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 1991; 148:997–1008
   PubMed Web of Science ®Google Scholar
• Thase ME, Buysse DJ, Frank E, Cherry CR, Comes CL, Mallinger AG, Kupfer DJ: Which depressed patients will respond to interpersonal psychotherapy? Am J Psychiatry 1997; 154:502–509
   PubMed Web of Science ®Google Scholar
• Frank E, Kupfer DJ, Perel JM, Comes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ: Three-year outcomes for maintenance therapies in recurrent depression. Archives of Gen Psychiatry 1990; 47:1093–1099
   PubMed Web of Science ®Google Scholar
• Bies RR, Bigos KU, Pollock BG: Gender differences in the phar-macokinetics and pharmacodynamics of antidepressants. J Gend Specif Med 2003; 6:12–20
   PubMedGoogle Scholar
• Yonkers KA, Kando JC, Cole JO, Blumental S: Gender differ-ences in the pharmacokinetics and pharmacodynamics of psycho-tropic medication. Am J Psychiatry 1992; 142:587–597
   Google Scholar
• Jensvold MF, Reed K, Jarrett DB, Hamilton JA: Menstrual cycle-related depressive symptoms treated with variable antidepressant dosage. J of Women's Health 1992; 1:109–115
   Google Scholar
• Kimmel S, Gonsalves L, Young D, Gidwani G: Fluctuating levels of antidepressants premenstrually. J Psychosom Obstet Gynecol 1992; 13:277–280
   Web of Science ®Google Scholar
• Pollock BG: Gender differences in psychotropic drug metabo-lism. Psychopharmacol Bull 1997; 33:235–241
   PubMed Web of Science ®Google Scholar
• Harris RZ, Benet LZ, Schwartz JB: Gender effects in pharmacok-inetics and pharmacodynamics. Drugs 1995; 50:222–239
   PubMed Web of Science ®Google Scholar
• Wisner KL, Perel JM, Wheeler SB: Tricyclic dose requirements across pregnancy. Am J Psychiatry 1993; 150:1541–1542
   PubMed Web of Science ®Google Scholar
• Komstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner JI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB: Gender differences in treatment response to ser-traline versus imipramine in chronic depression. Am J Psychiatry 2000; 157: 1445–1452
   Google Scholar
• Raskin A: Age sex differences in response to antidepressant drugs. J Nerv Ment Dis 1974; 159:120–130
   PubMed Web of Science ®Google Scholar
• Coppen A, Whybrow PC, Noguera R, Maggs R, Pange AJ Jr: The comparative antidepressive value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch Gen Psychaitry 1972; 26:234–241
   PubMed Web of Science ®Google Scholar
• Glassman AH, Perel JM, Shostak M, Kantor SJ, Fleiss JL: Clini-cal implications of imipramine plasma levels for depressive ill-ness. Arch Gen Psychiatry 1977; 34:197–204
   PubMed Web of Science ®Google Scholar
• Hamilton JA, Yonkers KA: Sex differences in pharmacokinetics of psychotropic medications. In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women. Washington DC: American Psychiatric Press Inc: 1996:11–41
   Google Scholar
• Martenyi F, Dossenbach M, Mraz K, Metcalfe S: Gender differ-ences in the efficacy of Fluoxetine and maprotiline in depressed patients: A double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibitation profile. Eur Neurop-sychopharmacol, 2001; 11:227–232
   PubMed Web of Science ®Google Scholar
• Quitkin FM, Stewart JW, McGrath PJ, Taylor BP, Tisminetzky MS, Petkova E, Chen Y, Ma G, Klein DF: Are there differences between women's and men's antidepressant responses? Am J Psy-chiatry 2002159:1848-1854
   PubMed Web of Science ®Google Scholar
• Grigoriadis S, Konarski J, Kennedy S, Mancini D, McIntyre RS: Sex differences in antidepressant response in a Canadian primary-care sample. J Clin Psychopharmacol 2007; 27:95–98
   Google Scholar
• Khan AF, Brodhead AE, Schwartz KA, Kolts RL, Brown WA: Sex differences in antidepressant response in recent antidepressant clinical trials. J Clinical Psychopharmacology 2005; 25:318–324
   PubMed Web of Science ®Google Scholar
• Joyce PR. Mulder RT, Luty SE, Sullivan PF, McKenzie JM, Abbott RM, Stevens IF: Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Aust N Z J Psychiatry 2002; 36:384–391
   PubMed Web of Science ®Google Scholar
• Baca E, Garcia-Garcia M, Porras-Chavarino A: Gender differ-ences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Progr Neuro Psychopharmacol Biol Psychiatr 2004; 28:57–65
   PubMed Web of Science ®Google Scholar
• Entsuah AR, Huang H, Thase ME: Response and remission rates in different subpopulations with major depressive disorder admin-istered venlafaxine, selective serotonin reuptake inhibitors, or pla-cebo. J Clin Psychiatry 2001; 11:869–877
   Google Scholar
• Parker G, Parker K, Austin MP, Mitchell P, Brotchie H: Gender differences in response to differing antidepressant drug classes: Two negative studies. Psychol Med 2003; 33:1473–1477
   PubMed Web of Science ®Google Scholar
• Hildebrandt MG, Steyerberg EW, Stage KB, Passchier J, Kragh-Soerensen P, Danish University Antidepressant group: Are gen-der differences important for the clinical effects of antidepres-sants? Am J Psychiatry 2003; 160:1643–1650
   PubMed Web of Science ®Google Scholar
• Wohlfarth T, Storosum JG, Elferink AJ, van Zwietanet BJ, Fouwels A, van den Brink W: Response to tricyclic antidepressants: Indepen-dent of gender? Am J Psychiatry 2004; 161:370–372
   PubMed Web of Science ®Google Scholar
• Cassano P. Soares CN, Cohen LS, Lyster AK, Fava M: Sex- and age-related differences in major depressive disorder with co mor-bid anxiety treated with fluoxetine. Arch Women's Ment Health 2004; 7:167–171
   Google Scholar
• Pinto-Meza A, Usall J, Serrano-Blanco A, Suarez D, Haro JM: Gender differences in response to antidepressant treatment pre-scribed in family care. Does menopause make a difference? J Affect Disord 2006; 93:53–60
   PubMed Web of Science ®Google Scholar
• Thiels C, Linden M, Grieger F, Leonard J: Gender differences in rou-tine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline. Int Clin Psychopharmacol 2005; 20:1–7
   PubMedGoogle Scholar
• Komstein SG, Wohlreich MM. Mallinckrodt CH, Watkin JG, Stewart DE: Duloxetine efficacy for major depressive disorder in male vs female patients: Data from 7 randomized double-blind, placebo-controlled trials. J Clin Psychiatry 2006; 67:761–770
   Google Scholar
• Entsuah AR, Cantillon M, Thase ME: Venalfaxine and SSRIs in the treatment of depression: Comparison among age and gender. Presented at: First World Congress on Women's Men-tal Health; 2001; Berlin, Germany
   Google Scholar
• Grigoriadis S, Kennedy SH, Bagby RM: A comparison of antide-pressant response in younger and older women. J Clin Psychop-harmacol 2003; 23:405–407
   PubMedGoogle Scholar
• Thase ME, Entsuah R, Cantillon M, Kornstein SG: Relative anti-depressant efficacy of venlafaxine and SSRls: Sex-age interac-tions. J Womens Health, 2005; 14:609–616
   PubMed Web of Science ®Google Scholar
• Joyce PR. Mulder RT, Luty SE, McKenzie JM, Rae AM: A dif-ferential response to nortriptyline and fluoxetine in melancholic depression: The importance of age and gender. Acta Psychiatr Scand 2003; 108:20–23
   PubMed Web of Science ®Google Scholar
• Grigoriadis S, Kennedy SH, Bouffard BA, Bagby RM, Joffe R: A comparison of desipramine response in older and younger women. Presented at: Canadian Psychiatric Association Confer-ence; 2004; Montreal Canada.
   Google Scholar
• Cassano P. Soares CN, Cusin C, Mascarini A, Cohen LS, Fava M: Antidepressant response and well-being in pre-, pen-, and postmenopausal women with major depressive dis-order treated with fluoxetine. Psychother and Psych osom 2005; 74:362–365
   Google Scholar
• Greenblatt DJ, Sellers EM, Shader RI: Drug disposition in old age. N Engl J Med 1982; 306:1081–1088
   PubMed Web of Science ®Google Scholar
• Schecter D: Estrogen, progesterone and mood. J Gender-Specific Med 1999; 2: 29–36
   Google Scholar
• Stoppe G, Doren M: Critical appraisal of effects of estrogen replacement therapy in symptoms of depressed mood. Arch Women Ment Health 2002; 5:39–47
   PubMedGoogle Scholar
• Cohen LS, Soares CN, Poitras JR, Prouty J, Alexander AB, Shi-fren IL: Short term use of estradiol for depression on perimeno-pausal and postmenopausal women: A preliminary report. Am J Psychiatry 2003; 160:1519–1522
   PubMed Web of Science ®Google Scholar
• Rasgon NE, Altshuler LL, Fairbanks L, Dunkin JJ, Davtyan C, Elman S, Rapkin AJ: Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry 2002; 63:45–48
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR: Estrogen replacement in perimeno-pause-related depression: A preliminary report. Am J Obstet Gynecol 2000; 183:414–420
   PubMed Web of Science ®Google Scholar
• Soares C, Almeida OP, Joffee H, Cohen LS: Efficacy of estra-diol for the treatment of depressive disorders in perimenopausal women. Arch Gen Psychiatry 2001; 58:529–534
   PubMed Web of Science ®Google Scholar
• Morrison MF, KaIlan MJ, Ten Have T, Katz I, Tweedy K, Battistini M: Lack of efficacy of estradiol for depression in postmenopausal women: A randomized, controlled trial. Biol Psychiatry 2004; 55:406–412
   PubMed Web of Science ®Google Scholar
• Saletu B, Brandstatter N, Metka M, Stamenkovic M, Anderer P. Semlitsch HV; Heytmanek G, Huber J, Grunberger J, Linzmayer, L: Double-blind, placebo-controlled, hormonal, syn-dromal and EEG mapping studies with transdermal estradiol therapy in menopausal depression. Psychopharmacol 1995; 122:321–329
   Google Scholar
• Amsterdam J, Garcia-Espana F, Fawcett J, Quitkin F, Reimherr F, Rosenbaum J, Beasley C: Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord 1999; 55:11–17
   PubMed Web of Science ®Google Scholar
• Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS: Estrogen replacement and response to fluoxet-ine in a multicenter geriatric depression trial. Am J Geriat Psy-chiatry 1997; 5:97–106
   PubMed Web of Science ®Google Scholar
• Schneider LS, Small GW, Clary C: Estrogen replacement ther-apy and antidepressant response to sertraline. Am J Geriat Psy-chiatry 2001; 9:393–399
   PubMed Web of Science ®Google Scholar
• Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren IL, Cohen LS: Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symp-toms. J Clin Psychiatry 2003; 64:473–479
   PubMed Web of Science ®Google Scholar
• Rasgon NL, Dunkin J, Fairbanks L, Altshuler LL, Troung C, Elman S, Wroolie TE, Brunhuber MV, Rapkin A: Estrogen and response to sertraline in postmenopausal women with major depressive disorder: A pilot study. J Psychiatr Res 2007; 41:338–343
   PubMed Web of Science ®Google Scholar